| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 83.1 | 68.8 | 70.9 |
| Other income | 0.8 | 0.6 | 0.1 |
| Total income | 83.9 | 69.4 | 71.0 |
| Profit before exceptional items & tax | 6.8 | 4.5 | 4.9 |
| Exceptional items | 0.0 | 0.0 | -2.6 |
| Profit before tax | 6.8 | 4.5 | 2.3 |
| Net profit | 4.9 | 3.3 | 1.2 |
| Operating margin | 8.1% | 6.5% | 3.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +308.30% |
|---|---|
| Net profit, quarter on quarter | +48.50% |
| Revenue, year on year | +17.20% |
| Operating profit, year on year | +25.00% |
| Operating profit, quarter on quarter | +53.80% |
BSE results filing, NSE: AMANTA. Figures extracted from the filing.
Amanta Healthcare Ltd: key numbers
- Share price
- ₹185.45
- Market cap
- ₹720.1 Cr
- Revenue (annual)
- ₹287.7 Cr
- Net profit (annual)
- ₹14.88 Cr
- P/E (TTM)
- 39.3×Sector 41.3×
- Promoter holding
- 63.80%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amanta Healthcare Ltd
All →Amanta Healthcare Investor Presentation: Key Takeaways
Q2FY27 revenue ₹83.1 Cr (+17.3% YoY), EBITDA ₹17.95 Cr (21.6% margin), PAT ₹4.86 Cr. H1 revenue ₹151.9 Cr, PAT ₹8.2 Cr. SteriPort Line 3 commissioned September 2026.
- Call
- Guides 20% growth
Amanta Healthcare Results Update
Amanta Healthcare reported Q2FY27 revenue of ₹83.13 crore and PAT of ₹4.86 crore, both up sharply YoY. SteriPort Line 3 was commissioned, raising bottle capacity to 11.6 crore.
- SteriPort bottle capacity
- 11.6 crore bottles
Amanta Healthcare Other Announcement
Amanta Healthcare's quarterly shareholding pattern as at 30 Sep 2026 shows promoter and promoter group holding at 31.33%. The filing notes a gift-based promoter group addition, but is a routine periodic disclosure.
Amanta Healthcare Management Change
Amanta Healthcare's COO Shri Anil Rathi resigned effective October 29, 2026. The departure is disclosed under Regulation 30 of the SEBI Listing Regulations.
Amanta Healthcare Board Meeting Date
Amanta Healthcare intimated a Board Meeting scheduled for 3 Nov 2026 to approve Q1 & H1 FY27 unaudited results. Trading window reopens on 6 Nov 2026.
Amanta Healthcare Other Announcement
Amanta Healthcare Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.